Mild cognitive impairment: pathology and mechanisms
Open accessThe DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“Although there have been many advances in clinically defining MCI [5, 43, 168], distinguishing brains at autopsy from people who died with a clinical diagnosis of no cognitive impairment (NCI) and MCI is challenging.”
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“The seminal findings of Roses and colleagues revealed that apolipoprotein E (APOE) e4 carriers are at increased risk for AD [32].”
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545 · cited 1×
“4c), which led to the cholinergic hypothesis of AD [11].”
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · cited 1×
“Biochemical [37] and histologic [187] investigations revealed a reduction in cortical cholinergic activity and loss of cholinergic basal forebrain (CBF) neurons (Fig.”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“Although both frontal and precuneus cortex develop amyloid pathology early in the disease process [84, 182], ChAT activity is only upregulated in the former [39] and stable in the latter cortical region in MCI [71].”
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · Focus · doi:10.1176/appi.focus.11.1.96 · Cited by 2,621
Self-citationAlzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Self-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“Although there have been many advances in clinically defining MCI [5, 43, 168], distinguishing brains at autopsy from people who died with a clinical diagnosis of no cognitive impairment (NCI) and MCI is challenging.”
Self-citationProfound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 3×
“5) suggesting that neuronal atrophy and death has already occurred at a time when patients begin to manifest clinical symptoms [54].”
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Self-citationHolmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · cited 1×
“decline in people with a clinical diagnosis of early AD [67].”
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060 · cited 1×
“In light of the recent finding that Ab normally functions as an antimicrobial peptide in the innate immune system in response to clinically relevant pathogenic microoorganisms, its removal may result in increased vulnerability to infection [167] and continued brain dysfunction.”
Frequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059
Self-citationNatural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037 · cited 2×
“A clinical pathologic study using a mixed cohort of MCI (aMCI and mdMCI) cases from the Rush Religious Orders Study (RROS), a clinical pathologic longitudinal study of aging and dementia [15, 109] found that ERC Aβ-amyloid peptide load in MCI cases appeared intermediate between controls and early AD, but the differenc…”
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“These investigations revealed no significant differences in synapse number in the outer molecular layer of the dentate gyrus between cognitively intact subjects and aMCI, whereas a milder AD group showed a significant loss of synapses compared to both NCI and aMCI [154].”
Self-citationThe neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824
Self-citationReiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 1×
“Imaging studies of presymptomatic e4 carriers have shown reduced cerebral glucose metabolism [162], increased cerebral amyloid deposition [139] and enhanced cortical atrophy [31] as well as accelerated memory decline [26].”
Self-citationCataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720
Neurotrophin Signaling Through the P75 Neurotrophin Receptor
Roux, P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00016-3 · Cited by 717
Snowdon, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530310034029 · Cited by 696 · cited 2×
“An examination of brains from two large autopsy populations, the Nun Study [140, 164, 165] and the National Alzheimer’s Coordinating Center (NACC) registry [13] failed to document an example of a truly end-stage NFT pathology coexisting with intact cognition [2].”
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686 · cited 6×
“cortex (SFC) in MCI subjects from the RROS [39, 73].”
InfluentialSelf-citationNeuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease
Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · cited 3×
“Clinical subtypes of MCI as well as many NCI cases have variable Braak staging scores ranging from a complete absence of NFTs (stage 0) to stages V/VI representing AD [109, 112, 114, 132, 137].”
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
Self-citationNeuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643 · cited 1×
“A broader evaluation of the distribution of NFTs indicate that they are significantly increased in the amygdala, entorhinal cortex (ERC), subiculum and the inferior parietal cortex (IPC) in MCI compared to controls suggesting that NFTs are critical for the transition to MCI [21, 58, 94, 118].”
Lopez, O. L., Jagust, W. J., DeKosky, S. T., Becker, J. T., Fitzpatrick, A., Dulberg, C., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1385 · Cited by 618
Self-citationTwo-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A., Ringheim, A., Langstrom, B., & Nordberg, A. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 617
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F., Jicha, G. A., Ivnik, R. J., Smith, G. E., Tangalos, E. G., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.665 · Cited by 616
Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease
Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596
Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia
Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006) · Movement Disorders · doi:10.1002/mds.20974 · Cited by 593
Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 587
Self-citationNeurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment
Guillozet, A. L., Weintraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 584
Neurotrophic factors and their receptors.
Barbacid, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80022-0 · Cited by 577
MRI measures of entorhinal cortex vs hippocampus in preclinical AD
Killiany, R. J., Hyman, B. T., Gomez-Isla, T., Moss, M. B., Kikinis, R., Jolesz, F., Tanzi, R., Jones, K., & Albert, M. S. (2002) · Neurology · doi:10.1212/wnl.58.8.1188 · Cited by 567
Berendsen, A. A. M., Kang, J. H., van de Rest, O., Jankovic, N., Kampman, E., Kiefte-de Jong, J. C., Franco, O. H., Ikram, M. A., Pikhart, H., Nilsson, L. M., et al. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000464269 · Cited by 562
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationLongitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., Baxter, L. C., Rapcsak, S. Z., Shi, J., Woodruff, B. K., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809437 · Cited by 528
Morris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513 · cited 1×
“Furthermore, ERC atrophy correlated with impairment on MMSE and clinical tests of declarative memory [87, 106], indicating that ERC neurodegeneration impacts the progression of MCI.”
Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
Davis, K. L. (1999) · JAMA · doi:10.1001/jama.281.15.1401 · Cited by 492
Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 483
Oxidative stress in Alzheimer disease: A possibility for prevention
Bonda, D. J., Wang, X., Perry, G., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 483
Lopez, O. L., Jagust, W. J., Dulberg, C., Becker, J. T., DeKosky, S. T., Fitzpatrick, A., Breitner, J., Lyketsos, C., Jones, B., Kawas, C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.10.1394 · Cited by 477 · cited 1×
“, congestive heart failure) and require medications for chronic illness, which may affect cognition, do not have aMCI as the predominant condition [90, 91].”
Self-citationNeuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460 · cited 2×
“By contrast, a recent study using samples from the University of Kentucky Alzheimer’s Disease Research Center (UKADRC) revealed that the brains of people without cognitive impairment and with a Braak score of II showed no differences in the number of DPs in the neocortex or limbic medial temporal lobe (MTL) structures…”
Nagele, R. G., D’Andrea, M. R., Anderson, W. J., & Wang, H.-Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00460-2 · Cited by 455
Quantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 1×
“Although neocortical synapse loss is a prominent feature of AD [97, 151], very few studies have reported changes in the MCI neocortex.”
Tau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F., & Berry, R. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 434
Self-citationThe National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.
Beekly, D. L., Ramos, E. M., van Belle, G., Deitrich, W. D., Clark, A. D., Jacka, M. E., & Kukull, W. A. (2004) · PubMed · Cited by 430
Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396 · cited 2×
“Since LC cytopathology correlates with overall cognition, noradrenergic dysfunction should be considered among the earliest cytopathologic lesions mediating the onset of cognitive decline in the aging-MCI continuum [57].”
Cataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06142.1997 · Cited by 393 · cited 1×
“Several studies indicate that endosomal and oxidative stress dysregulation are among the earliest pathological changes observed in cortical, hippocampal CA1 pyramidal and NB CBF neurons [28–30, 119–121, 163], which precede clinical symptoms and appear prior to substantial deposition of cerebral amyloid, vascular amylo…”
Riley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002) · Annals of Neurology · doi:10.1002/ana.10161 · Cited by 392
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
Mesulam, M., Shaw, P., Mash, D., & Weintraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 374
Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases
Nixon, R. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.018 · Cited by 370
Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease
Masliah, E., Terry, R. D., DeTeresa, R. M., & Hansen, L. A. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90582-x · Cited by 363
Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359
Bruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
Nordberg, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01125-2 · Cited by 339
Abdul, H. M., Sama, M. A., Furman, J. L., Mathis, D. M., Beckett, T. L., Weidner, A. M., Patel, E. S., Baig, I., Murphy, M. P., LeVine, H., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1064-09.2009 · Cited by 322
The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review
Nixon, R. A., Cataldo, A. M., & Mathews, P. M. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 318
Synaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer's Disease
Scheff, S. W., Price, D. A., Schmitt, F. A., Scheff, M. A., & Mufson, E. J. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101782 · Cited by 300
Self-citationGreeve, I., Hermans-Borgmeyer, I., Brellinger, C., Kasper, D., Gomez-Isla, T., Behl, C., Levkau, B., & Nitsch, R. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07345.2000 · Cited by 300
Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age
Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2009) · Annals of Neurology · doi:10.1002/ana.21696 · Cited by 299
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
Self-citationBRAAK, H., & BRAAK, E. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01146.x · Cited by 279
Cataldo, A. M., Paskevich, P. A., Kominami, E., & Nixon, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.10998 · Cited by 267
Ginsberg, S. D., Che, S., Wuu, J., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03764.x · Cited by 255
Self-citationMitchell, T. W., Mufson, E. J., Schneider, J. A., Cochran, E. J., Nissanov, J., Han, L., Bienias, J. L., Lee, V. M. ‐., Trojanowski, J. Q., Bennett, D. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10086 · Cited by 253
Self-citationEffect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e8d0 · Cited by 248 · cited 1×
“In fact, the total amyloid load in AD cases is higher in APOE e4 carriers than non-carriers [42].”
Aminergic systems in Alzheimer's disease and Parkinson's disease
D'Amato, R. J., Zweig, R. M., Whitehouse, P. J., Wenk, G. L., Singer, H. S., Mayeux, R., Price, D. L., & Snyder, S. H. (1987) · Annals of Neurology · doi:10.1002/ana.410220207 · Cited by 248
Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 245
Mufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L., Jaffar, S., Saragovi, H. U., & Kordower, J. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001106)427:1<19::aid-cne2>3.0.co;2-a · Cited by 243
Self-citationGinsberg, S. D., Alldred, M. J., Counts, S. E., Cataldo, A. M., Neve, R. L., Jiang, Y., Wuu, J., Chao, M. V., Mufson, E. J., Nixon, R. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.030 · Cited by 243
Self-citationTau phosphorylation in Alzheimer's disease: pathogen or protector?
Lee, H.-G., Perry, G., Moreira, P. I., Garrett, M. R., Liu, Q., Zhu, X., Takeda, A., Nunomura, A., & Smith, M. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.008 · Cited by 243
Grinberg, L. T., Rüb, U., Ferretti, R. E. L., Nitrini, R., Farfel, J. M., Polichiso, L., Gierga, K., Jacob‐Filho, W., Heinsen, H., & Brazilian Brain Bank Study Group (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00997.x · Cited by 241
Gilmor, M. L., Erickson, J. D., Varoqui, H., Hersh, L. B., Bennett, D. A., Cochran, E. J., Mufson, E. J., & Levey, A. I. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990906)411:4<693::aid-cne13>3.0.co;2-d · Cited by 239
Self-citationEntorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment
Mufson, E. J., Chen, E.-Y., Cochran, E. J., Beckett, L. A., Bennett, D. A., & Kordower, J. H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7086 · Cited by 237
Self-citationHeme oxygenase expression in human central nervous system disorders
Schipper, H. M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.015 · Cited by 237
Neuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236 · cited 2×
“A clinical pathologic study using a mixed cohort of MCI (aMCI and mdMCI) cases from the Rush Religious Orders Study (RROS), a clinical pathologic longitudinal study of aging and dementia [15, 109] found that ERC Ab-amyloid peptide load in MCI cases appeared intermediate between controls and early AD, but the differenc…”
Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.641 · Cited by 236
Self-citationThe Development of Amyloid β Protein Deposits in the Aged Brain
Thal, D. R., Capetillo-Zarate, E., Del Tredici, K., & Braak, H. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.6.re1 · Cited by 234 · cited 1×
“Senile plaques first appear as diffuse and “fleecy” [180] plaques throughout the neocortex and extend hierarchically into other brain regions.”
Takahashi, H., Sekino, Y., Tanaka, S., Mizui, T., Kishi, S., & Shirao, T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06586.2003 · Cited by 232
Mild cognitive impairment : aging to Alzheimer's disease
Petersen, R. C. (2003) · Cited by 223
Peng, S., Garzon, D. J., Marchese, M., Klein, W., Ginsberg, S. D., Francis, B. M., Mount, H. T. J., Mufson, E. J., Salehi, A., & Fahnestock, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4736-08.2009 · Cited by 217
Self-citationModulatory Role of Drebrin on the Cytoskeleton within Dendritic Spines in the Rat Cerebral Cortex
Hayashi, K., Ishikawa, R., Ye, L.-H., He, X.-L., Takata, K., Kohama, K., & Shirao, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07161.1996 · Cited by 217
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease.
(1990) · Europe PMC (PubMed Central) · Cited by 209
Pham, E., Crews, L., Ubhi, K., Hansen, L., Adame, A., Cartier, A., Salmon, D., Galasko, D., Michael, S., Savas, J. N., et al. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07719.x · Cited by 206
Systematic Regional Variations in the Loss of Cortical Cholinergic Fibers in Alzheimer's Disease
Geula, C., & Mesulam, M.-M. (1996) · Cerebral Cortex · doi:10.1093/cercor/6.2.165 · Cited by 202 · cited 1×
“By contrast, ChAT activity is increased in the MCI superior frontal [39] but reduced in the primary visual cortex, an area relatively spared in late stage [49] and mild-moderate AD cases [72].”
Mild Cognitive Impairment: Aging to Alzheimer’s Disease
(2003) · doi:10.1093/oso/9780195123425.001.0001 · Cited by 201
Hatanpää, K., Isaacs, K. R., Shirao, T., Brady, D. R., & Rapoport, S. I. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00008 · Cited by 200
Stoub, T. R., deToledo-Morrell, L., Stebbins, G. T., Leurgans, S., Bennett, D. A., & Shah, R. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603414103 · Cited by 199
Self-citationGlial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment
SCHIPPER, H., BENNETT, D., LIBERMAN, A., BIENIAS, J., SCHNEIDER, J., KELLY, J., & ARVANITAKIS, Z. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.016 · Cited by 199
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Self-citationIs Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer’s Disease?
Meyer, J. S., Xu, G., Thornby, J., Chowdhury, M. H., & Quach, M. (2002) · Stroke · doi:10.1161/01.str.0000024432.34557.10 · Cited by 195
The selective vulnerability of brainstem nuclei to Alzheimer's disease
Parvizi, J., Van Hoesen, G. W., & Damasio, A. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<53::aid-ana30>3.0.co;2-q · Cited by 193
MRI predictors of risk of incident Alzheimer disease: A longitudinal study
Stoub, T. R., Bulgakova, M., Leurgans, S., Bennett, D. A., Fleischman, D., Turner, D. A., & deToledo-Morrell, L. (2005) · Neurology · doi:10.1212/01.wnl.0000160089.43264.1a · Cited by 186
Self-citationReduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease
Counts, S. E., Nadeem, M., Wuu, J., Ginsberg, S. D., Saragovi, H. U., & Mufson, E. J. (2004) · Annals of Neurology · doi:10.1002/ana.20233 · Cited by 183
Self-citationDifferential Assembly of Human Tau Isoforms in the Presence of Arachidonic Acid
King, M. E., Gamblin, T. C., Kuret, J., & Binder, L. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741749.x · Cited by 179
Self-citationRegional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179
Andersen, O. M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D., McKinstry, W. J., Parker, M. W., Masters, C. L., Hyman, B. T., et al. (2006) · Biochemistry · doi:10.1021/bi052120v · Cited by 178 · cited 1×
“LR11 (also termed sorLA) is a multi-functional neuronal receptor that binds apolipoprotein E (ApoE), plays a crucial regulatory role in the processing of the amyloid precursor protein (APP) and may maintain low levels of the pathological form of the Aβ peptide [6, 7, 41, 123].”
Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease
García-Sierra, F., Ghoshal, N., Quinn, B., Berry, R. W., & Binder, L. I. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5201 · Cited by 177
Self-citationMild cognitive impairment clinical trials
Petersen, R. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1155 · Cited by 177
Sultana, R., Banks, W. A., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22227 · Cited by 170
Thal, D. R., Holzer, M., Rüb, U., Waldmann, G., Günzel, S., Zedlick, D., & Schober, R. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7380 · Cited by 162
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Bruno, M. A., Mufson, E. J., Wuu, J., & Cuello, A. C. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181c22569 · Cited by 162
Self-citationMRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study
Tapiola, T., Pennanen, C., Tapiola, M., Tervo, S., Kivipelto, M., Hänninen, T., Pihlajamäki, M., Laakso, M. P., Hallikainen, M., Hämäläinen, A., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.007 · Cited by 162
The amyloid pathology progresses in a neurotransmitter-specific manner
Bell, K. F. S., Ducatenzeiler, A., Ribeiro‐da‐Silva, A., Duff, K., Bennett, D. A., & Cuello, A. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.034 · Cited by 153
Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease
Rinne, J. O. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.113 · Cited by 153
Teaktong, T., Graham, A., Court, J., Perry, R., Jaros, E., Johnson, M., Hall, R., & Perry, E. (2003) · Glia · doi:10.1002/glia.10132 · Cited by 151 · cited 1×
“These results support a role for a7 nAChR in the development of cortical Ab pathology [117, 177] and potential functional interaction between a7nAChR and Ab [89].”
Ikonomović, M. D., Mufson, E. J., Wuu, J., Cochran, E. J., Bennett, D. A., & DeKosky, S. T. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5106 · Cited by 146
Self-citationVana, L., Kanaan, N. M., Ugwu, I. C., Wuu, J., Mufson, E. J., & Binder, L. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.044 · Cited by 138
Self-citationSalehi, A., Verhaagen, J., Dijkhuizen, P. A., & Swaab, D. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00273-4 · Cited by 137
LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease
Dodson, S. E., Gearing, M., Lippa, C. F., Montine, T. J., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228205.19915.20 · Cited by 134
Cholinergic system function and cognition in mild cognitive impairment
Haense, C., Kalbe, E., Herholz, K., Hohmann, C., Neumaier, B., Krais, R., & Heiss, W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.015 · Cited by 134
The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei
Rüb, U., Del Tredici, K., Schultz, C., Thal, D. R., Braak, E., & Braak, H. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2000.00291.x · Cited by 134
Aoki, C. J., Sekino, Y., Hanamura, K., Fujisawa, S., Mahadomrongkul, V., Ren, Y., & Shirao, T. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20449 · Cited by 127
α7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease
Counts, S., He, B., Che, S., Ikonomović, M. D., DeKosky, S. T., Ginsberg, S. D., & Mufson, E. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1771 · Cited by 121
Self-citationCorrelations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates
Chen, K., Reiman, E. M., Alexander, G. E., Caselli, R. J., Gerkin, R., Bandy, D., Domb, A., Osborne, D., Fox, N., Crum, W. R., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.916 · Cited by 119
Kalus, P., Slotboom, J., Gallinat, J., Mahlberg, R., Cattapan-Ludewig, K., Wiest, R., Nyffeler, T., Buri, C., Federspiel, A., Kunz, D., et al. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.10.035 · Cited by 117
Kendziorra, K., Wolf, H., Meyer, P., Barthel, H., Hesse, S., Becker, G., Luthardt, J., Schildan, A., Patt, M., Sorger, D., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1644-5 · Cited by 114
Hanyu, H., Asano, T., Sakurai, H., Tanaka, Y., Takasaki, M., & Abe, K. (2002) · PubMed · Cited by 114
Ginsberg, S. D., Che, S., Counts, S. E., & Mufson, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03641.x · Cited by 111
Self-citationLongitudinal Patterns of β-Amyloid Deposition in Nondemented Older Adults
Sojkova, J., Zhou, Y., An, Y., Kraut, M. A., Ferrucci, L., Wong, D. F., & Resnick, S. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.77 · Cited by 110
Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation
Halliday, G. M., McCann, H., Pamphlett, R., Brooks, W. S., Creasey, H. M., McCusker, E. A., Cotton, R. G. H., Broe, G. A., & Harper, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227741 · Cited by 109
Rate of entorhinal and hippocampal atrophy in incipient and mild AD: Relation to memory function
Stoub, T. R., Rogalski, E. J., Leurgans, S., Bennett, D. A., & deToledo-Morrell, L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.003 · Cited by 108
Self-citationTsang, S. W. Y., Lai, M. K. P., Kirvell, S. L., Francis, P. T., Esiri, M. M., Hope, T., Chen, C., & Wong, P. T. ‐. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.010 · Cited by 106
Bettens, K., Brouwers, N., Engelborghs, S., Deyn, P. P. D., Broeckhoven, C. V., & Sleegers, K. (2008) · Human Mutation · doi:10.1002/humu.20725 · Cited by 102
Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment
Adler, C. H., Caviness, J. N., Sabbagh, M. N., Shill, H. A., Connor, D. J., Sue, L. I., Evidente, V. G. H., Driver‐Dunckley, E. D., & Beach, T. G. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0744-4 · Cited by 101
Barone, E., Di Domenico, F., Cenini, G., Sultana, R., Coccia, R., Preziosi, P., Perluigi, M., Mancuso, C., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110092 · Cited by 98
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment
Sager, K. L., Wuu, J., Leurgans, S. E., Rees, H. D., Gearing, M., Mufson, E. J., Levey, A. I., & Lah, J. J. (2007) · Annals of Neurology · doi:10.1002/ana.21190 · Cited by 96
Self-citationShimohama, S., Kamiya, S., Taniguchi, T., Akagawa, K., & Kimura, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6940 · Cited by 95 · cited 1×
“Quantitative protein immunoblotting using tissue from clinically diagnosed MCI and either mild/moderate or severe AD from the RROS revealed decreased levels of synaptophysin selectively in the superior temporal cortex (STC) and inferior parietal cortex (IPC) in AD compared to NCI supporting findings in mild or severe…”
Potter, P. E., Rauschkolb, P. K., Pandya, Y., Sue, L. I., Sabbagh, M. N., Walker, D. G., & Beach, T. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0831-1 · Cited by 94 · cited 2×
“An analysis of frontal and parietal cortex demonstrated a reduction in ChAT activity and the coupling of M1 muscarinic acetylcholine receptor (mAChR) to G-proteins in non-demented elderly subjects with plaques compared to those without plaques using tissue from the Banner Institute Brain Bank, Phoenix, AZ, suggesting…”
Tremblay, C., Pilote, M., Phivilay, A., Émond, V., Bennett, D. A., & Calon, F. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12411 · Cited by 94
Neuropathology of mild cognitive impairment
Saito, Y., & Murayama, S. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00806.x · Cited by 92
Amyloid load in nondemented brains correlates with APOE e4
Caselli, R. J., Walker, D. G., Sue, L. I., Sabbagh, M. N., & Beach, T. G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.016 · Cited by 90
Hippocampal Drebrin Loss in Mild Cognitive Impairment
Counts, S. E., He, B., Nadeem, M., Wuu, J., Scheff, S. W., & Mufson, E. J. (2012) · Neurodegenerative Diseases · doi:10.1159/000333122 · Cited by 87
Self-citationMamidipudi, V., & Wooten, M. W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10244 · Cited by 84
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Wuu, J., Mathis, C. A., Scheff, S. W., Mufson, E. J., & DeKosky, S. T. (2011) · Neurology · doi:10.1212/wnl.0b013e3182231419 · Cited by 84
Self-citationMechanisms of AD neurodegeneration may be independent of Aβ and its derivatives
Robakis, N. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.022 · Cited by 72
Ikonomovic, M. D., Mufson, E. J., Wuu, J., Bennett, D. A., & DeKosky, S. T. (2005) · Archives of Neurology · doi:10.1001/archneur.62.3.425 · Cited by 72
Self-citationCortical α7 Nicotinic Acetylcholine Receptor and β-Amyloid Levels in Early Alzheimer Disease
Ikonomovic, M. D., Wecker, L., Abrahamson, E. E., Wuu, J., Counts, S. E., Ginsberg, S. D., Mufson, E. J., & DeKosky, S. T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.46 · Cited by 71
Self-citationIkonomovic, M. D., Abrahamson, E. E., Isanski, B. A., Wuu, J., Mufson, E. J., & DeKosky, S. T. (2007) · Archives of Neurology · doi:10.1001/archneur.64.9.1312 · Cited by 71
Self-citationKhachaturian, Z. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.04.003 · Cited by 68
Preservation of Brain Nerve Growth Factor in Mild Cognitive Impairment and Alzheimer Disease
Mufson, E. J., Ikonomović, M. D., Styren, S. D., Counts, S., Wuu, J., Leurgans, S. E., Bennett, D. A., Cochran, E. J., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1143 · Cited by 65
Self-citationRogalski, E. J., Murphy, C. M., deToledo‐Morrell, L., Shah, R. C., Moseley, M. E., Bammer, R., & Stebbins, G. T. (2009) · Behavioural Neurology · doi:10.1155/2009/408037 · Cited by 65
Self-citationMuth, K., Schönmeyer, R., Matura, S., Haenschel, C., Schröder, J., & Pantel, J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.026 · Cited by 64
MR features of the substantia innominata and therapeutic implications in dementias
Hanyu, H., Shimizu, S., Tanaka, Y., Hirao, K., Iwamoto, T., & Abe, K. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.009 · Cited by 63
Ellis, J. R., Villemagne, V. L., Nathan, P. J., Mulligan, R. S., Gong, S., Chan, J. G., Sachinidis, J. I., O'Keefe, G., Pathmaraj, K., Wesnes, K. A., et al. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.05.006 · Cited by 60
Is there a neuropathology difference between mild cognitive impairment and dementia?
Haroutunian, V. H., Hoffman, L. B., & Been, M. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/vharoutunian · Cited by 59
Lilja, A. M., Porras, O., Storelli, E., Nordberg, A., & Marutle, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101242 · Cited by 57 · cited 1×
“These results support a role for a7 nAChR in the development of cortical Ab pathology [117, 177] and potential functional interaction between a7nAChR and Ab [89].”
Sabbagh, M. N., Shah, F., Reid, R. T., Sue, L., Connor, D. J., Peterson, L. K. N., & Beach, T. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1771 · Cited by 57
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Forman, M. S., Mufson, E. J., Leurgans, S., Pratico, D., Joyce, S., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurology · doi:10.1212/01.wnl.0000256373.39415.b1 · Cited by 55
Self-citationSwaminathan, S., Shen, L., Risacher, S. L., Yoder, K. K., West, J. D., Kim, S., Nho, K., Foroud, T., Inlow, M., Potkin, S. G., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9136-1 · Cited by 54
MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD
George, S., Mufson, E. J., Leurgans, S. E., Shah, R. C., Ferrari, C., & deToledo‐Morrell, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.006 · Cited by 53
Self-citationShirao, T., INOUE, H. K., Kano, Y., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)91032-8 · Cited by 53
Association of SORL1 gene variants with Alzheimer's disease
Kölsch, H., Jessen, F., Wiltfang, J., Lewczuk, P., Dichgans, M., Teipel, S. J., Kornhuber, J., Frölich, L., Heuser, I., Peters, O., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.044 · Cited by 52
Chronological primacy of oxidative stress in Alzheimer disease
Smith, M. A., Nunomura, A., Lee, H., Zhu, X., Moreira, P. I., Ávila, J., & Perry, G. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.021 · Cited by 51
“End-Stage” Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction?
Abner, E. L., Kryscio, R. J., Schmitt, F. A., SantaCruz, K. S., Jicha, G. A., Lin, Y., Neltner, J. M., Smith, C. D., Van Eldik, L. J., & Nelson, P. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101980 · Cited by 49
Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease
Mufson, E. J., Wuu, J., Counts, S., & Nykjær, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.023 · Cited by 45
Self-citationAntioxidants and Reduced Functional Capacity in the Elderly: Findings From the Nun Study
Snowdon, D. A., Gross, M., & Butler, S. M. (1996) · The Journals of Gerontology Series A · doi:10.1093/gerona/51a.1.m10 · Cited by 43
MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.
Sasaki, M., Ehara, S., Tamakawa, Y., Takahashi, S., Tohgi, H., Sakai, A., & Mita, T. (1995) · PubMed · Cited by 42
Hanyu, H., Tanaka, Y., Sakurai, H., Takasaki, M., & Abe, K. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02507-1 · Cited by 37
Overk, C. R., Felder, C. C., Tu, Y., Schober, D. A., Bales, K. R., Wuu, J., & Mufson, E. J. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.03.005 · Cited by 36
Self-citationMitsis, E. M., Reech, K. M., Bois, F., Tamagnan, G. D., MacAvoy, M. G., Seibyl, J. P., Staley, J. K., & van Dyck, C. H. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.064030 · Cited by 36
Johnson, J. K., Pa, J., Boxer, A. L., Kramer, J. H., Freeman, K. M., & Yaffe, K. S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318836 · Cited by 34
5-123I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment
Terrière, E., Dempsey, M. F., Herrmann, L. L., Tierney, K. M., Lonie, J. A., O’Carroll, R. E., Pimlott, S. L., Wyper, D. J., Herholz, K., & Ebmeier, K. P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.008 · Cited by 30
Schmidt, M. L., Didario, A. G., Ötvös, L., Hoshi, N., Kant, J. A., Lee, V. M.-Y., & Trojanowski, J. Q. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1209 · Cited by 29
Decreases in soluble α-synuclein in frontal cortex correlate with cognitive decline in the elderly
Wang, D.-S., Bennett, D. A., Mufson, E. J., Cochran, E. J., & Dickson, D. W. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.044 · Cited by 24
Self-citationBeach, T. G., & McGeer, E. G. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90385-k · Cited by 20
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease
Minster, R. L., DeKosky, S. T., & Kamboh, M. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.010 · Cited by 7
Self-citationIC‐P‐071: Cholinergic and Neuropsychological Function in Mild Cognitive Impairment
Haense, C., Kalbe, E., Herholz, K., Hohmann, C., Neumaier, B., Krais, R., & Heiss, W. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.086 · Cited by 2
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J. S., Zhang, H., D’Amico, D., Moullan, N., Potenza, F., Schmid, A. W., Rietsch, S., et al. (2017) · Nature · doi:10.1038/nature25143 · Cited by 630
Self-citationBeyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0411-2 · Cited by 286
“For instance, neuropathological studies of MCI show similar results in the RROS [13, 67, 88], Washington University [100], and University of Kentucky [77] cohorts.”
Self-citationCoyle, H., Traynor, V., & Solowij, N. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.04.009 · Cited by 274
Metadata
- Authors
- Mufson, E. J., Binder, L., Counts, S. E., DeKosky, S. T., deToledo-Morrell, L., Ginsberg, S. D., Ikonomovic, M. D., Perez, S. E., & Scheff, S. W.
- Venue
- Acta Neuropathologica
- Published
- 2011-11-19
- Volume
- 123
- Issue
- 1
- Pages
- 13-30
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2048740905
- Cited by
- 257
- References
- 192
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.